Serum liver enzymes and risk of stroke: Systematic review with meta‐analyses and Mendelian randomization studies
European Journal of Neurology · 2024
DOI: 10.1111/ene.16506 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Chun Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Stroke, gamma-Glutamyltransferase, Liver. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Development and Application of Human Major Disease Monkey Model Key Laboratory of Sichuan Province, Luzhou Science and Technology Program, National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Background and purpose Previous observational studies have identified correlations between liver enzyme levels and stroke risk. However, the strength and consistency of these associations vary. To comprehensively evaluate the relationship between liver enzymes and stroke risk, we conducted meta‐analyses complemented by Mendelian randomization (MR) analyses.
Methods
Following the PRISMA guidelines, we performed meta‐analyses of prospective studies and conducted subgroup analyses stratified by sex and stroke subtype. Subsequently, adhering to the STROBE‐MR guidelines, we performed two‐sample bidirectional univariable MR (UVMR) and multivariable MR (MVMR) analyses using the largest genome‐wide association studies summary data. Finally, the single‐nucleotide polymorphisms associated with liver enzymes on sex differences underwent gene annotation, gene set enrichment, and tissue enrichment analyses.
Results
In the meta‐analyses of 17 prospective studies, we found the relative risks for serum γ‐glutamyl transferase (GGT) and alkaline phosphatase (ALP) were 1.23 (95% CI: 1.16–1.31) and 1.3 (95% CI: 1.19–1.43), respectively. Subgroup analyses revealed sex and stroke subtype differences in liver enzyme‐related stroke risk. Bidirectional UVMR analyses confirmed that elevated GGT, alanine aminotransferase, and aspartate aminotransferase levels were associated with increased stroke occurrence. The primary results from the MVMR analyses revealed that higher ALP levels significantly increased the risk of stroke and ischemic stroke. Gene set and tissue enrichment analyses supported genetic differences in liver enzymes across sexes.
Conclusions
Our study provides evidence linking liver enzyme levels to stroke risk, suggesting liver enzymes as potential biomarkers for early identification of high‐risk individuals. Personalized, sex‐specific interventions targeting liver enzymes could offer new strategies for stroke prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, China.
- Clinical Trial Research Center, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Laboratory of Neurological Diseases and Brain Function, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Key Laboratory of Luzhou City for Aging Medicine, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
- Central Nervous System Drug Key Laboratory of Sichuan Province, Luzhou, Sichuan, China.
- Department of Neurosurgery, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
ORCID-Profile: Chun Li
Förderung
- Development and Application of Human Major Disease Monkey Model Key Laboratory of Sichuan Province
- Luzhou Science and Technology Program
- National Natural Science Foundation of China
- Central Nervous System Drug Key Laboratory of Sichuan Province
Zitieren
APA
Li, C., Gu, L., Shi, F. Y., Xiong, S. Y., Wu, G. S., Peng, J. H., Wang, R. L., Yuan, Y., Jiang, Y., Huang, C., & Luo, H. R. (2024). Serum liver enzymes and risk of stroke: Systematic review with meta‐analyses and Mendelian randomization studies. European Journal of Neurology. https://doi.org/10.1111/ene.16506
Vancouver
Li C, Gu L, Shi FY, Xiong SY, Wu GS, Peng JH, et al. Serum liver enzymes and risk of stroke: Systematic review with meta‐analyses and Mendelian randomization studies. European Journal of Neurology. 2024. doi:10.1111/ene.16506
BibTeX
@article{Li2024,
author = {Li, Chun and Gu, Long and Shi, Fu-Yi and Xiong, Shi-Ying and Wu, Gui-Sheng and Peng, Jian-Hua and Wang, Ruo-Lan and Yuan, Yuan and Jiang, Yong and Huang, Chen and Luo, Huai-Rong},
title = {Serum liver enzymes and risk of stroke: Systematic review with meta‐analyses and Mendelian randomization studies},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16506}
}
EUVIMED